Bioculture Group is one of the world’s leading ethical suppliers of cynomolgus macaques (Macaca fascicularis) for biomedical research.
With over four decades of experience, we provide SPF-certified NHPs bred and cared for under the highest welfare and biosecurity standards, ensuring quality, reliability, and scientific integrity from source to study.
Non-human primates (NHPs) are a vital component of biomedical research due to their close genetic, anatomical, and physiological similarity to humans.
They provide a uniquely accurate model for understanding human biology and disease, especially in areas where alternative methods cannot replicate complex immune, neurological, or metabolic.

Testing safety and immunogenicity for diseases such as HIV, COVID-19 & malaria.

Evaluating delivery systems, biodistribution & vector safety.

Investigating drug metabolism, PK/PD & safety profiles.

Understanding CNS disorders & cognitive mechanisms.
Bioculture’s NHP supply network operates through two complementary entities, ensuring a seamless, compliant & transparent supply chain from Mauritius to the United States.
End-to-End Supply Chain Management:
Bioculture’s logistics system ensures secure, humane, and efficient transport of SPF macaques to approved research facilities worldwide.
Every stage, from pre-shipment health certification to arrival quarantine, is managed by trained specialists in compliance with international air transport and welfare standards.
Ethical compliance defines every aspect of Bioculture’s operations.
We work to ensure that our breeding, transportation, and research practices align with the strictest global standards for animal welfare and scientific integrity.